Foreskin inflammation is associated with HIV and herpes simplex virus type-2 infections in Rakai, Uganda

AIDS

Volumn 23, Issue 14, 2009, Pages 1807-1815

  Johnson, Kristine E ^a,h   Sherman, Mark E ^b   Ssempiija, Victor ^c,d   Tobian, Aaron A R ^a   Zenilman, Jonathan M ^a   Duggan, Maire A ^e   Kigozi, Godfrey ^c   Serwadda, David ^c,f   Wawer, Maria J ^d   Quinn, Thomas C ^a,g   Rabkin, Charles S ^b   Gray, Ronald H ^d  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f MAKERERE UNIVERSITY   (Uganda)

^g NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^h JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

Circumcision; Foreskin; Herpes simplex virus type 2; HIV; Inflammation; Uganda

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CELL COMPOSITION; CIRCUMCISION; CONTROLLED STUDY; DISEASE ASSOCIATION; EPITHELIUM; EVALUATION; GENITAL ULCER; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 2; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PHYSICAL EXAMINATION; POISSON DISTRIBUTION; PREPUCE; PREVALENCE; PRIORITY JOURNAL; SKIN INFLAMMATION; STROMA; UGANDA; VIRUS LOAD;

ADOLESCENT; ADULT; BALANITIS; CIRCUMCISION, MALE; FORESKIN; HERPES GENITALIS; HIV INFECTIONS; HIV-1; HUMANS; MALE; MIDDLE AGED; SEXUAL PARTNERS; UGANDA; VIRAL LOAD; YOUNG ADULT;

EID: 70249095636     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e32832efdf1     Document Type: Article

References (41)

1. Auvert B, Taljaard D, Lagarde E, Sobngwi-Tambekou J, Sitta R, Puren A. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005; 2:e298.
2. Bailey R, Moses S, Parker C, Agot K, Maclean I, Krieger JN, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369:643-656.
3. Gray RH, Kigozi G, Serwadda D, Makumbi F, Watya S, Nalu-goda F, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369:657-666.
4. Wawer MJ, Kigozi G, Serwadda D, Makumbi F, Nalugoda F, Watya S, et al. Trial of male circumcision in HIVR men, Rakai, Uganda: effects in HIVR men and in women partners. The 15th Annual Conference on Retroviruses and Opportunistic Infections; 2 April 2008. Boston, MA.
5. Tobian AA, Serwadda D, Quinn TC, Kigozi G, Gravitt PE, Laeyendecker O, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360:1298-1309.
6. GrosskurthH,Gray R, HayesR, Mabey D, Wawer M. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000; 355:1981-1987.
7. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HIV infection. Sex Transm Infect 1999; 75:3-17.
8. Stamm WE, Handsfield HH, Rompalo AM, Ashley RL, Roberts PL, Corey L. The association between genital ulcer disease and acquisition of HIV infection in homosexual men. JAMA 1988; 260:1429-1433.
9. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, Gakinya MN, et al. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J Infect Dis 1991; 163:233-239.
10. Laga M, Manoka A, Kivuvu M, Malele B, Tuliza M, Nzila N, et al. Nonulcerative sexually transmitted diseases as risk factors for HIV-1 transmission in women: results from a cohort study. AIDS 1993; 7:95-102.
11. Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2-seropositive persons: a meta-analysis. J Infect Dis 2002; 185:45-52.
12. Freeman EE, Weiss HA, Glynn JR, Cross PL, Whitworth JA, Hayes RJ. Herpes simplex virus 2 infection increases HIV acquisition in men and women: systematic review and meta-analysis of longitudinal studies. AIDS 2006; 20:73-83.
13. Reynolds SJ, Risbud AR, Shepherd ME, Zenilman JM, Brook-meyer RS, Paranjape RS, et al. Recent herpes simplex virus type 2 infection and the risk of human immunodeficiency virus type 1 acquisition in India. J Infect Dis 2003; 187:1513-1521.
14. Koelle DM, Abbo H, Peck A, Ziegweid K, Corey L. Direct recovery of herpes simplex virus (HSV)-specific T lymphocyte clones from recurrent genital HSV-2 lesions. J Infect Dis 1994; 169:956-961. (Pubitemid 24303211)
15. Corey L, Wald A, Celum CL, Quinn TC. The effects of herpes simplex virus-2 on HIV-1 acquisition and transmission: a review of two overlapping epidemics. J Acquir Immune Defic Syndr 2004; 35:435-445.
16. Castle PE, Hillier SL, Rabe LK, Hildesheim A, Herrero R, Bratti MC, et al. An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV). Cancer Epidemiol Biomarkers Prev 2001; 10:1021-1027.
17. Kovacic M, Katki HA, Kreimer A, Sherman ME. Epidemiologic analysis of histologic cervical inflammation: relationship to human papillomavirus infections. Human Pathol 2008; 39:1088-1095.
18. Bhoopat L, Eiangleng L, Rugpao S, Frankel SS, Weissman D, Lekawanvijit S, et al. In vivo identification of Langerhans and related dendritic cells infected with HIV-1 subtype E in vaginal mucosa of asymptomatic patients. Mod Pathol 2001; 14:1263-1269.
19. Patterson BK, Landay A, Siegel JN, Flener Z, Pessis D, Chaviano A, Bailey RC. Susceptibility to human immunodeficiency virus-1 infection of human foreskin and cervical tissue grown in explant culture. Am J Pathol 2002; 161:867-873.
20. Gamiel JL, Tobian AA, Laeyendecker OB, Reynolds SJ, Morrow RA, Serwadda D, et al. Improved performance of enzyme-linked immunosorbent assays and the effect of human immunodeficiency virus coinfection on the serologic detection of herpes simplex virus type 2 in Rakai, Uganda. Clin Vaccine Immunol 2008; 15:888-890.
21. Janeway CA, Travers P. Immunobiology: the immune system in health and disease. New York: Garland; 1997. pp. 9:13-9:20.
22. Luster AD. Chemokines -chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338:436-445.
23. Mbopi-Keou FX, Gresenguet G, Mayaud P, Weiss HA, Gopal R, Matta M, et al. Interactions between herpes simplex virus type 2 and human immunodeficiency virus type 1 infection in African women: opportunities for intervention. J Infect Dis 2000; 182:1090-1096.
24. Schacker T, Ryncarz AJ, Goddard J, Diem K, Shaughnessy M, Corey L, et al. Frequent recovery of HIV-1 from genital herpes simplex virus lesions in HIV-1-infected men. JAMA 1998; 280:61-66.
25. Rebbapragada A, Wachihi C, Pettengell C, Sunderji S, Huibner S, Jaoko W, Ball B. Negative mucosal synergy between Herpes simplex type 2 and HIV in the female genital tract. AIDS 2007; 21:589-598.
26. Levi G, Feldman J, Holman S, Salarieh A, Strickler HD, Alter S, Minkoff H. Relationship between HIV viral load and Langer-hans cells of the cervical epithelium. J Obstet Gynaecol Res 2005; 31:178-184.
27. Quayle AJ, Kourtis AP, Cu-Uvin S, Politch JA, Yang H, Bowman FP, et al. T-lymphocyte profile and total and virus-specific immunoglobulin concentrations in the cervix of HIV-1-infected women. J Acquir Immune Defic Syndr 2007; 44:292-298.
28. Taube JM, Nichols AD, Bornman LS, Bornman DM, Jackson JB. Langerhans cell density and high-grade vulvar intraepithelial neoplasia in women with human immunodeficiency virus infection. J Cutan Pathol 2007; 34:565-570.
29. Behbahani H, Walther-Jallow L, Klareskog E, Baum L, French AL, Patterson BK, et al. Proinflammatory and type 1 cytokine expression in cervical mucosa during HIV-1 and human pa-pillomavirus infection. J Acquir Immune Defic Syndr 2007; 45:9-19.
30. Weier S, Muller H, Stutte HJ, Kappus R, Berger S, Shah PM. Lymphocytes, Langerhans cells and CD68-positive monocytes/ macrophages in the skin of HIV-infected patients and normal controls. Verh Dtsch Ges Pathol 1991; 75:114-118.
31. Dreno B, Milpied B, Dutartre H, Litoux P. Epidermal interleukin 1 in normal skin of patients with HIV infection. Br J Dermatol 1990; 123:487-492.
32. Zhu J, Koelle DM, Cao J, Vazquez J, Huang ML, Hladik F, et al. Virus-specific CD8R T cells accumulate near sensory nerve endings in genital skin during subclinical HSV-2 reactivation. J Exp Med 2007; 204:595-603.
33. Tobian AA, Charvat B, Ssempijja V, Kigozi G, Serwadda D, Makumbi F, et al. Factors associated with the prevalence and incidence of herpes simplex virus type 2 infection among men in Rakai, Uganda. J Infect Dis 2009; 199:945-949.
34. Meier AS, Bukusi EA, Cohen CR, Holmes KK. Independent association of hygiene, socioeconomic status, and circumcision with reduced risk of HIV infection among Kenyan men. J Acquir Immune Defic Syndr 2006; 43:117-118.
35. Moore JE. The diagnosis of chancroid and the effect of prophylaxis upon its incidence in the American Expeditionary Forces. J Urol 1920; 4:169-176.
36. O'Farrell N. Soap and water prophylaxis for limiting genital ulcer disease and HIV-1 infection in men in sub-Saharan Africa. Genitourin Med 1993; 69:297-300.
37. Makumbi F, Gray RH, Wawer M, Nakigozi FG, Serwadda D, Kigozi G, et al. Male postcoital penile cleansing and the risk of HIV-acquisition in rural Rakai district, Uganda. The 4th International AIDS Society Meeting Abstract # WEAC1LB; Sydney, Australia; 25 July 2007.
38. Donoval BA, Landay AL, Moses S, Agot K, Ndinya-Achola JO, Nyagaya EA, et al. HIV-1 target cells in foreskins of African men with varying histories of sexually transmitted infections. Am J Clin Pathol 2006; 125:386-391.
39. Tokgoz H, Polat F, Tan MO, Erdem O, Bozkirli I. Histopatho-logical evaluation of the preputium in preschool and primary school boys. Int Urol Nephrol 2004; 36:573-576.
40. Feng JY, Peng ZH, Tang XP, Geng SM, Liu YP. Immunohisto-chemical and ultrastructural features of Langerhans cells in condyloma acuminatum. J Cutan Pathol 2008; 35:15-20.
41. McCoombe SG, Short RV. Potential HIV-1 target cells in the human penis. AIDS 2006; 20:1491-1495.